Form 4: Nutex Health President Warren Hosseinion Acquires Restricted Stock Units

Warren Hosseinion, President of Nutex Health, Inc., reports the acquisition of 113,265 Restricted Stock Units (RSUs) on June 28, 2024, which will vest in three equal installments.

Summary

• Warren Hosseinion, President of Nutex Health, Inc., filed a Form 4 on June 28, 2024.
• The filing reports the acquisition of 113,265 Restricted Stock Units (RSUs).
• These RSUs represent a contingent right to receive one share of Nutex Health's common stock upon vesting.
• The RSUs will vest in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock units being granted, which is neither particularly positive nor negative on its own.

Positives

• The acquisition of RSUs by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in the healthcare industry.

Stakeholder Impact

• The granting of RSUs to the President may incentivize him to improve company performance, potentially benefiting shareholders.

Key Dates